dr. brahmer on the role of immunotherapy in metastatic nsclc
Published 5 years ago • 63 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
0:31
copy of dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:32
dr. brahmer on the benefit of immunotherapy in metastatic nsclc
-
7:10
the role of immunotherapy in metastatic nsclc
-
1:14
dr. brahmer on immunotherapy in stage iv nsclc
-
1:59
dr. brahmer on side effects of immunotherapy for lung cancer
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
1:25
dr. brahmer on chemoimmunotherapy in patients with nsclc
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
0:19
copy of dr. brahmer on immunotherapy in stage iv nsclc
-
1:53
dr. brahmer on the role of pd-1 and pd-l1
-
0:58
dr. julie r. brahmer on immunotherapy development in lung cancer
-
1:05
dr. brahmer on the impower150 trial in nsclc
-
2:19
dr brahmer on the investigation of flx475 in nsclc
-
1:18
dr. brahmer on 5-year follow-up data for nivolumab in nsclc
-
1:21
dr. julie brahmer on the pd-1 targeted immunotherapy bms-93655 clinical trial
-
1:22
dr. bauml on the use of immunotherapy in oligometastatic nsclc
-
1:23
dr. brahmer on biomarkers for immune response in nsclc
-
1:56
dr. brahmer discusses the future of antibodies for lung cancer
-
3:51
the role of immunotherapy in oncology